福莫诺尼丁通过KLF6/STAT3通路调节巨细胞极化,缓解缺血性急性损伤
Ning-Xin Zhang1, Chen Guan1, Chen-Yu Li2
1Department of Nephrology, The Affiliated Hospital of Qingdao University, Qingdao, China.
The American journal of Chinese medicine
|August 21, 2024
概括
甲米诺尼丁通过减少炎症来保护损伤. 这项研究表明,它通过KLF6/STAT3通路抑制了亲炎性巨细胞两极分化,为急性损伤提供了潜在的治疗方法.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 在各种疾病中,诺尼丁表现出抗炎性质.
- 在急性损伤 (AKI) 中,诺尼丁对无菌炎症的影响尚不清楚.
研究的目的:
- 调查蒙尼丁对缺血症/再输血诱导的AKI (IRI-AKI) 的保护作用.
- 在AKI中探索蒙尼丁的潜在抗炎机制,重点关注巨细胞两极分化和KLF6/STAT3通路.
主要方法:
- 利用IRI-AKI小鼠模型和骨髓衍生的巨细胞 (BMDMs).
- 通过血清肌和血液尿素水平评估功能.
- 分析了病理,管状损伤标志物 (KIM-1,NGAL),促炎细胞因子和巨细胞透.
- 在实验室中对巨细胞极化进行了研究,并研究了KLF6/STAT3通路.
主要成果:
- 在IRI-AKI小鼠中,甲诺丁治疗显著保留了功能,并减少了管损伤.
- 甲状腺素抑制了促炎性细胞因子表达 (MCP-1,TNF-α,IL-1β) 并降低了巨细胞的透.
- 在体外,甲诺丁抑制了与KLF6/STAT3通路调节相关的LPS/IFN-γ诱导的炎症性巨细胞极化.
结论:
- 在IRI-AKI中,甲状腺素显示出显著的保护和抗炎作用.
- 该机制涉及抑制KLF6/STAT3介导的炎症性巨细胞两极分化.
- 福蒙诺丁是治疗IRI-AKI的一种有前途的治疗候选药物.
更多相关视频
03:13Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
Published on: November 3, 2023
2.2K
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
368
相关概念视频
01:22Acute Kidney Injury I: Introduction
1.4K
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
1.4K
01:29Acute Kidney Injury II: Pathophysiology
2.3K
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
2.3K
01:29Acute Kidney Injury III: Clinical Manifestations
1.8K
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.8K
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
559
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
559
01:20Acute Kidney Injury V: Interprofessional Care
527
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
527